These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 23300777

  • 1. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
    Kobayashi Y, Okada Y, Itakura G, Iwai H, Nishimura S, Yasuda A, Nori S, Hikishima K, Konomi T, Fujiyoshi K, Tsuji O, Toyama Y, Yamanaka S, Nakamura M, Okano H.
    PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
    [Abstract] [Full Text] [Related]

  • 2. LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.
    Ito S, Nagoshi N, Kamata Y, Kojima K, Nori S, Matsumoto M, Takei K, Nakamura M, Okano H.
    Stem Cell Reports; 2021 Nov 09; 16(11):2703-2717. PubMed ID: 34653401
    [Abstract] [Full Text] [Related]

  • 3. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
    Kawai M, Imaizumi K, Ishikawa M, Shibata S, Shinozaki M, Shibata T, Hashimoto S, Kitagawa T, Ago K, Kajikawa K, Shibata R, Kamata Y, Ushiba J, Koga K, Furue H, Matsumoto M, Nakamura M, Nagoshi N, Okano H.
    Cell Rep; 2021 Nov 23; 37(8):110019. PubMed ID: 34818559
    [Abstract] [Full Text] [Related]

  • 4. Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
    Shibata T, Tashiro S, Shibata S, Shinozaki M, Shindo T, Hashimoto S, Kawai M, Kitagawa T, Ago K, Matsumoto M, Nakamura M, Okano H, Nagoshi N.
    Stem Cells Transl Med; 2023 Mar 03; 12(2):83-96. PubMed ID: 36647673
    [Abstract] [Full Text] [Related]

  • 5. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
    Itakura G, Kobayashi Y, Nishimura S, Iwai H, Takano M, Iwanami A, Toyama Y, Okano H, Nakamura M.
    PLoS One; 2015 Mar 03; 10(2):e0116413. PubMed ID: 25706286
    [Abstract] [Full Text] [Related]

  • 6. Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.
    Okubo T, Iwanami A, Kohyama J, Itakura G, Kawabata S, Nishiyama Y, Sugai K, Ozaki M, Iida T, Matsubayashi K, Matsumoto M, Nakamura M, Okano H.
    Stem Cell Reports; 2016 Oct 11; 7(4):649-663. PubMed ID: 27666789
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic Neural Stem/Progenitor Cells Derived From Embryonic Stem Cells Promote Functional Recovery After Transplantation Into Injured Spinal Cord of Nonhuman Primates.
    Iwai H, Shimada H, Nishimura S, Kobayashi Y, Itakura G, Hori K, Hikishima K, Ebise H, Negishi N, Shibata S, Habu S, Toyama Y, Nakamura M, Okano H.
    Stem Cells Transl Med; 2015 Jul 11; 4(7):708-19. PubMed ID: 26019226
    [Abstract] [Full Text] [Related]

  • 8. Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets.
    Yamane J, Nakamura M, Iwanami A, Sakaguchi M, Katoh H, Yamada M, Momoshima S, Miyao S, Ishii K, Tamaoki N, Nomura T, Okano HJ, Kanemura Y, Toyama Y, Okano H.
    J Neurosci Res; 2010 May 15; 88(7):1394-405. PubMed ID: 20091712
    [Abstract] [Full Text] [Related]

  • 9. Treatment with a Gamma-Secretase Inhibitor Promotes Functional Recovery in Human iPSC- Derived Transplants for Chronic Spinal Cord Injury.
    Okubo T, Nagoshi N, Kohyama J, Tsuji O, Shinozaki M, Shibata S, Kase Y, Matsumoto M, Nakamura M, Okano H.
    Stem Cell Reports; 2018 Dec 11; 11(6):1416-1432. PubMed ID: 30503258
    [Abstract] [Full Text] [Related]

  • 10. Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.
    López-Serrano C, Torres-Espín A, Hernández J, Alvarez-Palomo AB, Requena J, Gasull X, Edel MJ, Navarro X.
    Cell Transplant; 2016 Oct 11; 25(10):1833-1852. PubMed ID: 27075820
    [Abstract] [Full Text] [Related]

  • 11. Transplantation of neural stem/progenitor cells at different locations in mice with spinal cord injury.
    Iwai H, Nori S, Nishimura S, Yasuda A, Takano M, Tsuji O, Fujiyoshi K, Toyama Y, Okano H, Nakamura M.
    Cell Transplant; 2014 Oct 11; 23(11):1451-64. PubMed ID: 23998989
    [Abstract] [Full Text] [Related]

  • 12. In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.
    Tanimoto Y, Yamasaki T, Nagoshi N, Nishiyama Y, Nori S, Nishimura S, Iida T, Ozaki M, Tsuji O, Ji B, Aoki I, Jinzaki M, Matsumoto M, Fujibayashi Y, Zhang MR, Nakamura M, Okano H.
    Stem Cells Transl Med; 2020 Apr 11; 9(4):465-477. PubMed ID: 31904914
    [Abstract] [Full Text] [Related]

  • 13. A robust culture system to generate neural progenitors with gliogenic competence from clinically relevant induced pluripotent stem cells for treatment of spinal cord injury.
    Kamata Y, Isoda M, Sanosaka T, Shibata R, Ito S, Okubo T, Shinozaki M, Inoue M, Koya I, Shibata S, Shindo T, Matsumoto M, Nakamura M, Okano H, Nagoshi N, Kohyama J.
    Stem Cells Transl Med; 2021 Mar 11; 10(3):398-413. PubMed ID: 33226180
    [Abstract] [Full Text] [Related]

  • 14. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.
    Yasuda A, Tsuji O, Shibata S, Nori S, Takano M, Kobayashi Y, Takahashi Y, Fujiyoshi K, Hara CM, Miyawaki A, Okano HJ, Toyama Y, Nakamura M, Okano H.
    Stem Cells; 2011 Dec 11; 29(12):1983-94. PubMed ID: 22028197
    [Abstract] [Full Text] [Related]

  • 15. hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice.
    Kong D, Feng B, Amponsah AE, He J, Guo R, Liu B, Du X, Liu X, Zhang S, Lv F, Ma J, Cui H.
    Stem Cell Res Ther; 2021 Mar 11; 12(1):172. PubMed ID: 33706803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice.
    Nori S, Okada Y, Yasuda A, Tsuji O, Takahashi Y, Kobayashi Y, Fujiyoshi K, Koike M, Uchiyama Y, Ikeda E, Toyama Y, Yamanaka S, Nakamura M, Okano H.
    Proc Natl Acad Sci U S A; 2011 Oct 04; 108(40):16825-30. PubMed ID: 21949375
    [Abstract] [Full Text] [Related]

  • 18. Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury.
    Kawabata S, Takano M, Numasawa-Kuroiwa Y, Itakura G, Kobayashi Y, Nishiyama Y, Sugai K, Nishimura S, Iwai H, Isoda M, Shibata S, Kohyama J, Iwanami A, Toyama Y, Matsumoto M, Nakamura M, Okano H.
    Stem Cell Reports; 2016 Jan 12; 6(1):1-8. PubMed ID: 26724902
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury.
    Nishimura S, Yasuda A, Iwai H, Takano M, Kobayashi Y, Nori S, Tsuji O, Fujiyoshi K, Ebise H, Toyama Y, Okano H, Nakamura M.
    Mol Brain; 2013 Jan 08; 6():3. PubMed ID: 23298657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.